Pamlab Can't Bar Virtus' Marketing In Unfair Competition Row

Law360, New York (December 4, 2013, 5:04 PM EST) -- A Florida federal judge on Tuesday denied Nestle Health Science-Pamlab's bid for a preliminary injunction to block Virtus Pharmaceuticals LLC from marketing a generic version of prescription medical foods, saying the suit is based on unfair competition claims and not harm to patients.

Pamlab had asked the court to block Virtus from selling and distributing its prescription products that Virtus claims to contain certain amounts of the ingredient L-Methylfolate, but which Pamlab says only contain about one-half the amounts represented.

The medical foods product company had...
To view the full article, register now.




Case Information

Case Title

Nestle Health Science-Pamlab. et al v. Virtus Pharmaceuticals, LLC

Case Number



Florida Southern

Nature of Suit

Other Statutory Actions


Kathleen M. Williams

Date Filed

October 29, 2012

Law Firms


UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.